Indication
Anal Canal Intraepithelial Neoplasia
1 clinical trial
1 product
Clinical trial
HPV Vaccine to Interrupt Progression of Vulvar and Anal Neoplasia (VIVA) Trial: A Randomized, Double-Blind, Placebo-Controlled TrialStatus: Terminated, Estimated PCD: 2022-12-31